Relationship between immunosuppression and intensive care unit-acquired colonization and infection related to multidrug-resistant bacteria: a prospective multicenter cohort study

被引:20
|
作者
Kreitmann, Louis [1 ,2 ]
Vasseur, Margot [1 ]
Jermoumi, Sonia [1 ]
Perche, Juliette [3 ]
Richard, Jean-Christophe [4 ]
Wallet, Florent [5 ,6 ]
Chabani, Myriam [2 ]
Nourry, Emilie [2 ]
Garcon, Pierre [7 ]
Zerbib, Yoann [8 ]
Van Grunderbeeck, Nicolas [9 ]
Vinsonneau, Christophe [10 ]
Preda, Cristian [11 ,12 ]
Labreuche, Julien [13 ]
Nseir, Saad [1 ,14 ]
机构
[1] CHU Lille, Med Intens Reanimat, F-59000 Lille, France
[2] Hosp Civils Lyon, Hop Edouard Herriot, Med Intens Reanimat, F-69437 Lyon 03, France
[3] Hop Roubaix, Serv Reanimat, Roubaix, France
[4] Hosp Civils Lyon, Hop Croix Rousse, Med Intens Reanimat, F-69004 Lyon, France
[5] Hosp Civils Lyon, Grp Hosp Sud, Serv Reanimat, F-69637 Pierre Benite, France
[6] Claude Bernard Lyon Univ, Ctr Int Rech Infectiol CIRI, ENS Lyon, CNRS UMR5308,INSERM U1111, Villeurbanne, France
[7] Grand Hop Est Francilien, Reanimat, Site Marne La Vallee, Jossigny, France
[8] Ctr Hosp Univ Amiens Picardie, Med Intens Reanimat, Amiens, France
[9] Ctr Hosp Lens, Serv Reanimat Polyvalente, Lens, France
[10] Hop Bethune, Intens Care Unit, F-62408 Bethune, France
[11] Grp Hop Inst Catholique Lille, Dept Med Res, Biostat, Lille, France
[12] Univ Lille, Lab Paul Painleve, CNRS UMR 8524, F-59000 Lille, France
[13] CHU Lille, Dept Biostat, F-59000 Lille, France
[14] Univ Lille, CNRS, Inserm U1285, UMR 8576 UGSF, F-59000 Lille, France
关键词
Intensive Care Unit; Antimicrobial resistance; Cross infection; Immunocompromised host; Patient isolation; CLINICAL-PRACTICE GUIDELINES; LACTAMASE-PRODUCING ENTEROBACTERIACEAE; DISEASES SOCIETY; RISK-FACTORS; DIAGNOSIS; OUTCOMES; MANAGEMENT; THERAPY; UPDATE; ADULTS;
D O I
10.1007/s00134-022-06954-0
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Purpose: The impact of immunosuppression on intensive care unit (ICU)-acquired colonization and infection related to multidrug-resistant (MDR) bacteria (ICU-MDR-col and ICU-MDR-inf, respectively) is unknown. Methods: We carried out an observational prospective cohort study in 8 ICUs in France (all with single-bed rooms and similar organizational characteristics). All consecutive patients with an ICU stay > 48 h were included, regardless of immune status, and followed for 28 days. Patients underwent systematic screening for colonization with MDR bacteria upon admission and every week subsequently. Immunosuppression was defined as active cancer or hematologic malignancy, neutropenia, solid-organ transplant, use of steroids or immunosuppressive drugs, human immunodeficiency virus infection and genetic. The primary endpoint was the incidence rate of a composite outcome including ICU-MDR-col and/or ICU-MDR-inf. Results: 750 patients (65.9% males, median age 65 years) were included, among whom 264 (35.2%) were immunocompromised. Reasons for ICU admission, severity scores and exposure to invasive devices and antibiotics during ICU stay were comparable between groups. After adjustment for center and pre-specified baseline confounders, immunocompromised patients had a lower incidence rate of ICU-MDR-col and/or ICU-MDR-inf (adjusted incidence ratio 0.68, 95% CI 0.52-0.91). When considered separately, the difference was significant for ICU-MDR-col, but not for ICU-MDR-inf. The distribution of MDR bacteria was comparable between groups, with a majority of Enterobacteriacae resistant to third-generation cephalosporins (similar to 74%). Conclusion: Immunocompromised patients had a significantly lower incidence rate of a composite outcome including ICU-MDR-col and/or ICU-MDR-inf. This finding points to the role of contact precautions and isolation measures, and could have important implications on antibiotic stewardship in this population.
引用
收藏
页码:154 / 165
页数:12
相关论文
共 50 条
  • [1] Relationship between immunosuppression and intensive care unit-acquired colonization and infection related to multidrug-resistant bacteria: a prospective multicenter cohort study
    Louis Kreitmann
    Margot Vasseur
    Sonia Jermoumi
    Juliette Perche
    Jean-Christophe Richard
    Florent Wallet
    Myriam Chabani
    Emilie Nourry
    Pierre Garçon
    Yoann Zerbib
    Nicolas Van Grunderbeeck
    Christophe Vinsonneau
    Cristian Preda
    Julien Labreuche
    Saad Nseir
    Intensive Care Medicine, 2023, 49 : 154 - 165
  • [2] Relationship between COVID-19 and ICU-acquired colonization and infection related to multidrug-resistant bacteria: a prospective multicenter before-after study
    Kreitmann, Louis
    Jermoumi, Sonia
    Vasseur, Margot
    Chabani, Myriam
    Nourry, Emilie
    Richard, Jean-Christophe
    Wallet, Florent
    Garcon, Pierre
    Kachmar, Safaa
    Zerbib, Yoann
    Van Grunderbeeck, Nicolas
    Vinsonneau, Christophe
    Duhamel, Alain
    Labreuche, Julien
    Nseir, Saad
    INTENSIVE CARE MEDICINE, 2023, 49 (07) : 796 - 807
  • [3] Relationship between COVID-19 and ICU-acquired colonization and infection related to multidrug-resistant bacteria: a prospective multicenter before-after study
    Louis Kreitmann
    Sonia Jermoumi
    Margot Vasseur
    Myriam Chabani
    Emilie Nourry
    Jean-Christophe Richard
    Florent Wallet
    Pierre Garçon
    Safaâ Kachmar
    Yoann Zerbib
    Nicolas Van Grunderbeeck
    Christophe Vinsonneau
    Alain Duhamel
    Julien Labreuche
    Saad Nseir
    Intensive Care Medicine, 2023, 49 : 796 - 807
  • [4] Multidrug-resistant bacteria colonization amongst patients newly admitted to a geriatric unit: A prospective cohort study
    Schoevaerdts, Didier
    Verroken, Alexia
    Huang, Te-Din
    Frennet, Malorie
    Berhin, Catherine
    Jamart, Jacques
    Bogaerts, Pierre
    Swine, Christian
    Glupczynski, Youri
    JOURNAL OF INFECTION, 2012, 65 (02) : 109 - 118
  • [5] β-Lactam allergy and risk of multidrug-resistant bacteria in the intensive care unit: A cohort study
    Strazzulla, Alessio
    Iordache, Laura
    de Pontfarcy, Astrid
    Pitsch, Aurelia
    Belfeki, Nabil
    Jochmans, Sebastien
    Lezmi, Guillaume
    Monchi, Mehran
    Diamantis, Sylvain
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (01)
  • [6] Recognition and prevention of multidrug-resistant Gram-negative bacteria in the intensive care unit
    Maragakis, Lisa L.
    CRITICAL CARE MEDICINE, 2010, 38 (08) : S345 - S351
  • [7] Impact of a targeted isolation strategy at intensive-care-unit-admission on intensive-care-unit-acquired infection related to multidrug-resistant bacteria: a prospective uncontrolled before-after study
    Ledoux, G.
    Six, S.
    Lawson, R.
    Labreuche, J.
    Blazejewski, C.
    Wallet, F.
    Duhamel, A.
    Nseir, S.
    CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (10) : 888.e11 - 888.e18
  • [8] Occurrence of colonization and infection with multidrug-resistant organisms in a neonatal intensive care unit
    Dedeic-Ljubovic, Amela
    Hukic, Mirsada
    MEDICINSKI GLASNIK, 2012, 9 (02) : 304 - 310
  • [9] Remifentanil discontinuation and subsequent intensive care unit-acquired infection: a cohort study
    Saad Nseir
    Jérémy Hoel
    Guillaume Grailles
    Aude Soury-Lavergne
    Christophe Di Pompeo
    Daniel Mathieu
    Alain Durocher
    Critical Care, 13
  • [10] Association between mortality and highly antimicrobial-resistant bacteria in intensive care unit-acquired pneumonia
    Lakbar, Ines
    Medam, Sophie
    Ronfle, Romain
    Cassir, Nadim
    Delamarre, Louis
    Hammad, Emmanuelle
    Lopez, Alexandre
    Lepape, Alain
    Machut, Anais
    Boucekine, Mohamed
    Zieleskiewicz, Laurent
    Baumstarck, Karine
    Savey, Anne
    Leone, Marc
    SCIENTIFIC REPORTS, 2021, 11 (01)